Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer
Exploring additional biomarkers will likely become a key focus in future clinical trials to accurately select patients with low risk of local recurrence and further stratify these already low-risk individuals
For both ingredients, a few universal principles apply: patch test before full-face use, introduce one active at a time, avoid combining with incompatible ingredients, and stop use if you experience persistent irritation, allergic reaction, or unexpected pigmentary change
A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment
Timing and consistency Consistency matters more than perfection
Frequently Asked Questions What is BPC-157